Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.88
-0.07 (-0.70%)
Nov 20, 2026, 4:00 PM EST - Market closed
Bioventus Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Bioventus stock has a consensus rating of "Strong Buy" and an average price target of $16.6. The average 1-year stock price forecast is 68.02% higher than the current stock price, while the lowest is $15 (+51.82%) and the highest is $18 (+82.19%).
Price Target: $16.6 (+68.02%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bioventus stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +51.82% | Nov 13, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +61.94% | Nov 3, 2026 |
| Barrington | Barrington | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +61.94% | Nov 3, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $19 → $18 | Buy | Reiterates | $19 → $18 | +82.19% | Nov 3, 2026 |
Financial Forecast
Revenue This Year
594.93M
from 568.09M
Increased by 4.72%
Revenue Next Year
633.08M
from 594.93M
Increased by 6.41%
EPS This Year
0.77
from 0.68
Increased by 12.94%
EPS Next Year
0.89
from 0.77
Increased by 15.63%
EPS and Forward PE are based on non-GAAP adjusted numbers.